|
Roscoe Brady, M.D., has dedicated most of his research career to unveiling the mysteries surrounding human hereditary metabolic disorders. His accomplishments include identifying the metabolic defects in lipid storage disorders such as Gaucher, Niemann-Pick, Fabry, and Tay-Sachs disease. He and his coworkers were responsible for establishing the effectiveness of enzyme replacement therapy in Gaucher disease. Most recently he served as Chief of the Developmental and Metabolic Neurology Branch in the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
An undergraduate at Pennsylvania State University from 1941 to 1943, Dr. Brady then made his way to Harvard Medical School, where he graduated in 1947. Dr. Brady interned at the hospital of the University of Pennsylvania. From 1948 to 1952, he was a research fellow at the University of Pennsylvania medical school's physiological chemistry department, and a clinical fellow in the endocrine section of the Department of Medicine. In 1954, he began his career at the National Institutes of Health.
He has published over 500 scientific articles, and is the editor of five scientific journals. Dr. Brady is a recipient of the Gairdner Foundation International Award, the Distinguished Service Award from the Department of Health, Education and Welfare, the Poiley Award from the New York Academy of Science, the Cotzias Award from the American Academy of Neurology, the Pasano Foundation Award, the Lasker Foundation Clinical Medical Research Award, and the Kovalenko Medal from the National Academy of Sciences USA. Pennsylvania State granted him their distinguished Alumni Award in 1981, and the New York University honored him with their prestigious School of Medicine Award for Research in Neurogenetics in 1998. He is a member of the National Academy of Sciences, USA and a member of the Institute of Medicine of the National Academy of Sciences. | 